|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2022
vol. 124 abstract:
Original paper
The influence of escitalopram therapy on macular function in patients with major depression – preliminary report
Wojciech Lubiński
1
,
Hanna Grabek-Kujawa
1
,
Ewa Dańczura
2
,
Jolanta Kucharska-Mazur
2
,
Jerzy Samochowiec
2
,
Maciej Mularczyk
3
KLINIKA OCZNA 2022, 124, 1: 25–30
Online publish date: 2022/03/25
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
To analyze macular function after escitalopram treatment in patients with major depression. Material and methods In 21 newly diagnosed (42 eyes) patients (mean age: 46.4 ±11.6 years) with major depression (MD), and in 29 (58 eyes) age- and sex-matched healthy controls (mean age: 46.3 ±10.4 years) the following examinations were performed: visual acuity (Snellen Table), intraocular pressure, biomicroscopy of anterior and posterior segment of the eye and macular structure (SD-OCT-Zeiss). In the MD group, before and after 4 weeks of escitalopram treatment, a pattern electroretinogram (PERG) was registered and amplitudes (A) of P50 and N95 waves and peak times (PT) of P50 waves were analyzed. An analysis of the correlation between post-treatment changes of PERG parameters and depression severity (Hamilton Depression Rating Scale – HAMD) was achieved. The results were considered as a statistically significant with p < 0.05. Results In the MD group and healthy control the clinical results were normal. After treatment in the PERG test, significant shortening of PTP50 mean (p = 0.03) was detected. The amplitudes of P50 and N95 waves did not change significantly. Correlations between analyzed PERG parameters and HAMD score before and after treatment were not found (p > 0.05) but in MD patients in whom after treatment the change from severe to mild (using scores of HAMD) was achieved, a significant positive correlation (p = 0.04) between reduction of HAMD score and shortening of the PTP50 wave was found. Conclusions In patients with MD after escitalopram treatment, the improvement of bioelectrical macular function was detected. The PERG has a potential value to be useful, objective test in estimation of the treatment success. keywords:
escitalopram, major depression, PERG |
|
POLSKI
